Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors

Giovanna L. Delogu
Primo
;
Amit Kumar;Gianluca Gatto;
2021-01-01

Abstract

A new series of 2-phenylbenzofuran derivatives were designed and synthesized to determine relevant structural features for the MAO inhibitory activity and selectivity. Methoxy substituents were introduced in the 2-phenyl ring, whereas the benzofuran moiety was not substituted or substituted at the positions 5 or 7 with a nitro group. Substitution patterns on both the phenyl ring and the benzofuran moiety determine the affinity for MAO-A or MAO-B. The 2-(3-methoxyphenyl)-5-nitrobenzofuran 9 was the most potent MAO-B inhibitor (IC50 = 0.024 µM) identified in this series, whereas 7-nitro-2-phenylbenzofuran 7 was the most potent MAO-A inhibitor (IC50 = 0.168 µM), both acting as reversible inhibitors. The number and position of the methoxyl groups on the 2-phenyl ring, have an important influence on the inhibitory activity. Molecular docking studies confirmed the experimental results and highlighted the importance of key residues in enzyme inhibition.
2021
Inglese
107
104616
1
11
11
https://www.sciencedirect.com/science/article/pii/S0045206820319143?via=ihub
Esperti anonimi
internazionale
scientifica
2-Phenylbenzofurans; Monoamine oxidase inhibitors; Docking studies
Delogu, Giovanna L.; Kumar, Amit; Gatto, Gianluca; Bustelo, Fernando; Saavedra, Lucía M.; Isabel Rodríguez-Franco, Maria; Laguna, Reyes; Viña, Dolores ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
8
reserved
File in questo prodotto:
File Dimensione Formato  
Bioorganic Chemistry 107 (2021) 104616.pdf

Solo gestori archivio

Descrizione: articolo online
Tipologia: versione editoriale
Dimensione 2.43 MB
Formato Adobe PDF
2.43 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie